Starting at a low dose and increasing slowly helps reduce nausea, vomiting, constipation, diarrhea, reflux, abdominal discomfort, and dehydration
The semaglutide dosing structure and tirzepatide dosing guide provide reference frames for understanding where you are in the escalation process
[20] [21] The proposed mechanisms include inhibition of disaccharidase enzymes in the small intestine, which may slow the breakdown and absorption of other sugars, and potential stimulation of GLP-1 secretion from intestinal L-cells
Key features of retatrutide include: Acts as a triple agonist on GLP-1, GIP, and glucagon
The ADA recommends a target A1c below 6.5% before conception when this can be achieved safely
Expect 1-5 lbs of weight loss in the first 1-2 weeks, primarily due to fluid loss, reduced food intake, and appetite suppression